Victoria Bîrluţiu
University lecturer – Clinic of Infectious Diseases, Sibiu
Abstract
Nosocomial infections are known for the severity of the clinical symptoms and the reserved prognosis due to the involvement of multidrugresistant germs, most of which are frequently identifi ed as Staphylococcus aureus, Pseudomonas aeruginosa, E coli, Klebsiella pneumoniae extended-spectrum β-lactamase production (ESBL +); during the past two decades we have witnessed an alarming increase in the occurrence of the Acinetobacter baumanii multiresistant infections in the intensive care units (ICU), surgical units, thus turning into a fearful emergent pathogen agent. We decided to describe the clinical aspects associated to Acinetobacter baumanii nosocomial infections in the County Emergency Clinical Hospital in Sibiu and also their present susceptibility to antibiotherapy, evolution and prognosis. Nosocomial infections were generated by Acinetobacter in 95 cases out of 258, in tumoral diseases in 23 cases, politrauma or abdominal surgical interventions – 9 cases each, fractures – 13 cases with an unfavorable evolution in 7 cases. Th e sensitivity of the isolated stems is preserved in the cases of colistin – 98.15%, meropenem – 93.75% and imipenem – 86.02%.